Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
Running, not enrolling · Not applicable
Conditions studied: No Evidence of Disease, BRCA1 Syndrome, BRCA2 Syndrome, Hereditary Female Breast Carcinoma, Hereditary Ovarian Carcinoma
In brief
This pilot clinical trial studies a culturally-informed counseling intervention in Latinas at high risk for hereditary breast or ovarian cancer. A culturally-informed counseling intervention may be an effective method to help people learn more about their cancer risk.
Key facts
- Study ID
- NCT01230346
- Run by
- City of Hope Medical Center
- People needed
- 493
- Starts
- 2010-09-03
- Expected to finish
- 2026-09-25
- Last updated by the study team
- 2025-11-10
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Individuals who have a personal history of hereditary breast or ovarian cancer; a subset of 60 women without a personal history of hereditary or ovarian cancer will be included in an exploratory subset analysis
- Meet NCCN criteria for consideration of genetic testing for hereditary breast cancer
- Willing to sign consent
- Pregnant women and women of child-bearing potential are eligible for participation in this study
- Women who report themselves to be of Latino or Hispanic ethnic background (defined as Spanish, Mexican, Central or South American, Cuban, Puerto Rican, Dominican, or other Hispanic origin)
- Women who are under- or uninsured and come from low-income communities
- Ability to understand English or Spanish
You may not qualify if…
- Previous participation in GCRA
Where it is running
- City of Hope Medical Center — Duarte, California, United States
- University of Southern California-Keck School of Medicine — Los Angeles, California, United States
- Olive View-UCLA Medical Center — Sylmar, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.